Theseus Pharmaceuticals Inc (THRX)

NASDAQ
15.80
+0.16(+1.02%)
  • Volume:
    162,743
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    14.11 - 16.59

THRX Overview

Prev. Close
15.64
Day's Range
14.11-16.59
Revenue
-
Open
15.48
52 wk Range
12.75-24.54
EPS
-
Volume
162,743
Market Cap
597.04M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
321,564
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
37,787,174
Next Earnings Date
01 Mar 2022
What is your sentiment on Theseus Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Theseus Pharmaceuticals Inc Company Profile

Employees
13

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-variant inhibitor for activating and resistance mutations of the KIT kinase or a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors (GIST), a type of cancer characterized by oncogenic activation of KIT. The company also develops fourth-generation EGFR inhibitor that is active against C797S, an EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralSellNeutral
Technical IndicatorsStrong BuyBuyStrong BuyStrong SellStrong Buy
SummaryStrong BuyBuyBuyStrong SellBuy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.